PDLIM7 and lung adenocarcinoma: Huang et al.61 described that exogenous treatment with C2-ceramide triggered lysosomal pathways in T cell hybridomas and A549 lung adenocarcinoma cells and that C2-ceramide might have no direct effect on lysosomal function because the inhibition of ASM did not affect LMP or apoptosis.